Kaempferol attenuates diet-induced obesity and hepatic steatosis in C57BL/6J mice fed an Indian diet-mimicking regimen

Figure 3 Kaempferol alleviates the liver function parameters and triglyceride levels in an ex-vivo precision-cut liver slice model. A: For alanine aminotransferase, data represented in mean ± SD (n = 3), ^aP < 0.0001 [control, vs palmitic acid (PA)-treated, 240 μM]; ^bP < 0.0001 (PA-treated, 240 μM vs kaempferol, 25 μM); ^cP < 0.0001 (PA-treated, 240 μM vs kaempferol, 50 μM); B: For aspartate aminotransferase, data represented in mean ± SD (n = 3), ^aP < 0.001 [control vs PA-treated, 240 μM]; ^bP < 0.001 (PA-treated, 240 μM vs kaempferol, 25 μM); ^cP < 0.001 (PA-treated, 240 μM vs kaempferol, 50 μM); C: For alkaline phosphatase, data represented in mean ± SD (n = 3), ^aP < 0.05 [control vs PA-treated, 240 μM]; ^bP < 0.05 (PA-treated, 240 μM vs kaempferol, 25 μM); ^cP < 0.05 (PA-treated, 240 μM vs kaempferol, 50 μM); D: For triglycerides, data represented in mean ± SD (n = 3), ^aP < 0.001 [control vs PA-treated, 240 μM]; ^bP < 0.001 (PA-treated, 240 μM vs kaempferol, 25 μM); ^cP < 0.001 (PA-treated, 240 μM vs kaempferol, 50 μM); ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; PA: Palmitic acid; KMF: Kaempferol.